Name | MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE "APTEKA N 23" |
|---|
INN | 7527000270 |
|---|
KPP | 752701001 |
|---|
OGRN | 1027500952940 |
|---|
OKPO | 1905453 |
|---|
Address | 673370, Zabaykal'skiy Kray, r-n Shilkinskiy, g. Shilka, ul. Lenina, d. D. 74 |
|---|
Phone | +7 (302) 442-41-25 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 68.20.2 | Additional activity | Renting and operating of own or leased commercial properties and non- residential buildings |
Registration date | 19.11.2002 |
|---|
Registering department | Administratsiya Shilkinskogo rayona |
|---|
|
MUP "APTEKA N 23" (Zabaykalsky Krai; INN 7527000270) was registered on 19 Nov 2002. The company's authorized capital as of July 1, 2012 was 100000 rub. Type of ownership of MUP "APTEKA N 23" - Unitary enterprises based on the principle of economic management. Form of ownership of MUP "APTEKA N 23" - Municipal property. Principal activities of MUP "APTEKA N 23": retailing drugs in specialized stores (pharmacies) (47.73), renting and operating of own or leased commercial properties and non- residential buildings (68.20.2). |
Economic indicators2023
Net profit (RAS) of MUP APTEKA N 23 grew over 2023 by 17.53% to 1.58 million RUB from 1.35 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 2.11% to 43.57 million RUB from 44.50 million RUB in 2022; cost of goods sold decreased by 2.55% to 31.16 million RUB from 31.97 million RUB; sales profit fell by 1.27% to 2.02 million RUB from 2.05 million RUB. 2022
Net profit (RAS) of MUP APTEKA N 23 grew over 2022 by 5.16% to 1.35 million RUB from 1.28 million RUB over 2021, the company informed. Revenue increased in the accounting period by 1.43% to 44.50 million RUB from 43.88 million RUB over 2021; cost of goods sold remained at the same level amounting to 31.97 million RUB compared to 31.96 million RUB; sales profit fell by 3.67% to 2.05 million RUB from 2.13 million RUB. 2021
Net profit (RAS) of MUP APTEKA N 23 dropped in 2021 by 25.49% to 1.28 million RUB from 1.72 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 5.44% to 43.88 million RUB from 46.40 million RUB in 2020; cost of goods sold decreased by 7.31% to 31.96 million RUB from 34.48 million RUB; sales profit fell by 12.76% to 2.13 million RUB from 2.44 million RUB. 2020
Net profit (RAS) of MUP APTEKA N 23 dropped in 2020 by 19.16% to 1.68 million RUB from 2.08 million RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 6.53% to 46.37 million RUB from 43.52 million RUB over 2019; cost of goods sold grew by 8.43% to 34.48 million RUB from 31.80 million RUB; sales profit fell by 8.80% to 2.40 million RUB from 2.64 million RUB. 2019
Net profit (RAS) of MUP APTEKA N 23 grew over 2019 by 33.70% to 2.08 million RUB from 1.56 million RUB over 2018, the company informed. Revenue increased in the accounting period by 16.43% to 43.52 million RUB from 37.38 million RUB over 2018; cost of goods sold grew by 15.08% to 31.80 million RUB from 27.63 million RUB; sales profit went up by 47.26% to 2.64 million RUB from 1.79 million RUB. 2018
Net profit (RAS) of MUP APTEKA N 23 grew over 2018 by 15.75% to 1.56 million RUB from 1.35 million RUB over 2017, the company informed. Revenue increased in the accounting period by 14.33% to 37.38 million RUB from 32.70 million RUB over 2017; cost of goods sold grew by 14.82% to 27.63 million RUB from 24.07 million RUB; sales profit went up by 10.29% to 1.79 million RUB from 1.62 million RUB. 2017
Net profit (RAS) of MUP APTEKA N 23 dropped in 2017 by 47.85% to 1.35 million RUB from 2.58 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 6.87% to 32.70 million RUB from 35.11 million RUB in 2016; cost of goods sold decreased by 2.20% to 24.07 million RUB from 24.61 million RUB; sales profit fell by 40.04% to 1.62 million RUB from 2.71 million RUB. 2016
Net profit (RAS) of MUP APTEKA N 23 grew over 2016 4.64 times to 2.58 million RUB from 556.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period by 2.41% to 35.11 million RUB from 34.28 million RUB over 2015; cost of goods sold grew by 1.09% to 24.61 million RUB from 24.34 million RUB; sales profit went up 2.26 times to 2.71 million RUB from 1.20 million RUB. 2014
Net profit (RAS) of MUUP APTEKA N 23 made up 1.03 million RUB over 2014 compared to net loss of 25.00 thousand RUB over 2013, the company informed. Revenue increased in the accounting period by 4.24% to 34.38 million RUB from 32.98 million RUB over 2013; cost of goods sold grew by 3.60% to 24.41 million RUB from 23.56 million RUB; sales profit fell by 31.43% to 1.03 million RUB from 1.51 million RUB. 2013
Net loss (RA) of MUUP APTEKA N 23 made up 25.00 thousand RUB over 2013 compared to net profit of 1.00 million RUB over 2012, the company informed. Revenue increased in the accounting period by 2.81% to 32.98 million RUB from 32.08 million RUB over 2012; cost of goods sold grew by 1.46% to 23.56 million RUB from 23.22 million RUB; sales profit fell by 3.28% to 1.51 million RUB from 1.56 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|